GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now gaining a significant focus in medical investigation, largely due to its impressive impact on managing ailments such as type 2 diabetes and excess body fat. Ongoing research have shown that beyond glucose control, GLP-1 agonists offer potential for heart function and possibly brain